Skip to main content



) --

Antares Pharma



) hit a new 52-week high Tuesday as it is currently trading at $3.82, above its previous 52-week high of $3.75 with 1.2 million shares traded as of 11:04 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.

Antares has a market cap of $344.1 million and is part of the

health care

sector and

health services

industry. Shares are up 50% year to date as of the close of trading on Monday.

TheStreet Recommends

Antares Pharma Inc., a pharmaceutical company, engages in the development and marketing of self-injection pharmaceutical products and technologies, and topical gel-based products.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

TheStreet Ratings rates Antares as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full

Antares Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center